# Cellerix

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/cellerix-s-a

- Industry: Pharmaceuticals
- Headquarters: Madrid, Spain
- Website: www.cellerix.com
- Total disclosed funding: $76M
- Latest round: Series C (Jan 29, 2010)
- Investors on record: 8

## About

Founded in 2004 and based in Madrid, Spain, Cellerix S.A. operates as a biopharmaceutical company focused on the development and production of innovative medicinal products based on cell therapy.

## Funding rounds

- Series C, Jan 29, 2010, $38M — Ventech, Novartis Venture Fund, Ysios Capital Partners, Roche Venture Fund
- Series B, Sep 20, 2007, $39M — Ventech, Novartis Venture Fund, EQT Life Sciences, Genetrix, Ysios Capital Partners, Genera Capital, Roche Venture Fund, BioPartner Start-up Ventures

## Investors

- Ventech (https://capitalatlas.ai/funds/ventech) — Series B, Series C
- Novartis Venture Fund (https://capitalatlas.ai/funds/novartis-venture-fund) — Series B, Series C
- EQT Life Sciences (https://capitalatlas.ai/funds/eqt-life-sciences) — Series B
- Genetrix (https://capitalatlas.ai/funds/genetrix) — Series B
- Ysios Capital Partners (https://capitalatlas.ai/funds/ysios-capital-partners) — Series B, Series C
- Genera Capital (https://capitalatlas.ai/funds/genera-capital) — Series B
- Roche Venture Fund (https://capitalatlas.ai/funds/roche-venture-fund) — Series B, Series C
- BioPartner Start-up Ventures (https://capitalatlas.ai/funds/biopartner-start-up-ventures) — Series B